LHX vs PRAX · P/E 34, rev $5.88B vs $7.38B cap
L3Harris Technologies Inc (LHX) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the LHX and PRAX stock pages for the full models.
Not investment advice.